Manufacturing Efficiency and Supply Chain Security

• Siddharth J. Advant, Ph.D., Head, Biotech Sector, Tunnell Consulting
• Chris Antoniou, Principal Engineer, Global Engineering and Technology, Biogen Idec
• Barak I. Barnoon, Director, Biotech Process Engineering, Wyeth
• Jon T. Conary, Ph.D., Senior Director, Manufacturing, Human Genome Sciences, Inc.
• Duncan Low, Ph.D., Scientific Executive Director, Process Development, Amgen, Inc.
• Wolfgang Noe, Ph.D., Vice President, Strategic Development and Technical Alliance, Biogen Idec
• James M. Robinson, Vice President Technical and Quality Operations, Novavax, Inc.
• Victor A. Vinci, Ph.D., Director, Bioprocess Operations, Eli Lilly and Company

Scaling up from Bench through Commercialization: Worldwide Regulatory Interface

• Jeffrey C. Baker, Ph.D., Senior Director, Manufacturing Sciences, MedImmune
• Roger A. Hart, Ph.D., Scientific Director, Process Development, Amgen
• Maninder Hora, Ph.D., Vice President, Product Operations, Facet Biotech Corporation
• Dr. Guenter Jagschies, Senior Director R&D, Strategic Customer Relations , GE Healthcare Life Sciences, Sweden
• Ellen L. McCormick, Director, BioProcess R&D, Pfizer, Inc
• Tom Ransohoff, Senior Consultant, BioProcess Technology Consultants, Inc.
• David H. Reifsnyder, Ph.D., Principal Scientist, Biopharmaceutical Development, Genentech, Inc.
• Abhinav Shukla, Ph.D., Associate Director Manufacturing Sciences, Bristol-Myers Squibb

Cell Culture and Upstream Processing Track

• Timothy Charlebois, Ph.D., Senior Director, Drug Substance Development, Wyeth Biopharma
• Srikanth Chary, Ph.D., Senior Engineer, Cell Culture Process R&D, Genentech, Inc.
• Kevin Kayser, Ph.D., R&D Manager, Cell Culture Engineering, SAFC Biosciences
• Dennis Kraichely, Ph.D., Principal Research Scientist, Expression Technologies, Centocor Inc.
• Adekunle Onadipe, Ph.D., Global Research & Development, Pfizer Inc
• Charles Sardonini, Ph.D., Associate Director, Process Engineering/Development, Genzyme Corp.
• Thomas Seewoester, Ph.D., Director, Process Development, Amgen Inc.
• Kelly Wiltburger, Senior Manager, Biopharm Development, Biogen Idec
• Paul Wu, Ph.D., Director, Upstream Development, Global Biological Development, Bayer HealthCare

Recovery & Purification

• Jim Davies, Ph.D., Principal Group Leader, Purification Development, Lonza Biologics PLC, United Kingdom
• Chris Dowd, Ph.D., Senior Engineer, Late Stage Purification, Genentech, Inc.
• Sanchayita Ghose, Ph.D., Manager, Process Sciences Downstream, Bristol-Myers Squibb
• Uwe Gottschalk, Ph.D., Vice President, Purification Technology, Sartorius Stedim Biotech, Germany
• Brian R. Hubbard, Ph.D., Scientific Executive Director, Process and Analytical Sciences, Amgen
• David W. Kahn, Ph.D., Director, Late-Stage Purification Development, Human Genome Sciences, Inc.
• Rick Rutter, Ph.D., Vice President, Pharmaceutical Sciences, Biologics, Pfizer Inc
• Peter W. Wojciechowski, Director, Process and Analytical CMC, Johnson and Johnson Regenerative Therapeutics